HRP20171573T1 - Čvrsti oblik derivata dihidro-pirido-oksazina - Google Patents
Čvrsti oblik derivata dihidro-pirido-oksazina Download PDFInfo
- Publication number
- HRP20171573T1 HRP20171573T1 HRP20171573TT HRP20171573T HRP20171573T1 HR P20171573 T1 HRP20171573 T1 HR P20171573T1 HR P20171573T T HRP20171573T T HR P20171573TT HR P20171573 T HRP20171573 T HR P20171573T HR P20171573 T1 HRP20171573 T1 HR P20171573T1
- Authority
- HR
- Croatia
- Prior art keywords
- form according
- anhydrous crystalline
- crystalline form
- therapeutically effective
- pyrido
- Prior art date
Links
- 239000007787 solid Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 108091007960 PI3Ks Proteins 0.000 claims 1
- 102000001708 Protein Isoforms Human genes 0.000 claims 1
- 108010029485 Protein Isoforms Proteins 0.000 claims 1
- 238000002441 X-ray diffraction Methods 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 238000010586 diagram Methods 0.000 claims 1
- 238000000113 differential scanning calorimetry Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000000634 powder X-ray diffraction Methods 0.000 claims 1
- 238000001228 spectrum Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GC201222895 | 2012-11-26 | ||
| PCT/IB2013/060412 WO2014102630A1 (en) | 2012-11-26 | 2013-11-26 | Solid form of dihydro-pyrido-oxazine derivative |
| EP13824177.3A EP2928896B1 (en) | 2012-11-26 | 2013-11-26 | Solid form of dihydro-pyrido-oxazine derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20171573T1 true HRP20171573T1 (hr) | 2017-11-17 |
Family
ID=54198861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20171573TT HRP20171573T1 (hr) | 2012-11-26 | 2017-10-17 | Čvrsti oblik derivata dihidro-pirido-oksazina |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JP6310474B2 (es) |
| EA (1) | EA028031B1 (es) |
| ES (1) | ES2643902T3 (es) |
| HR (1) | HRP20171573T1 (es) |
| HU (1) | HUE036665T2 (es) |
| LT (1) | LT2928896T (es) |
| MA (1) | MA38100A1 (es) |
| SI (1) | SI2928896T1 (es) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110172217A1 (en) * | 2008-09-05 | 2011-07-14 | Shionogi & Co., Ltd. | Ring-fused morpholine derivative having pi3k-inhibiting activity |
| KR101656592B1 (ko) * | 2011-12-22 | 2016-09-23 | 노파르티스 아게 | 디히드로-벤조-옥사진 및 디히드로-피리도-옥사진 유도체 |
-
2013
- 2013-11-26 JP JP2015543559A patent/JP6310474B2/ja active Active
- 2013-11-26 MA MA38100A patent/MA38100A1/fr unknown
- 2013-11-26 HU HUE13824177A patent/HUE036665T2/hu unknown
- 2013-11-26 LT LTEP13824177.3T patent/LT2928896T/lt unknown
- 2013-11-26 SI SI201330781T patent/SI2928896T1/sl unknown
- 2013-11-26 EA EA201591023A patent/EA028031B1/ru not_active IP Right Cessation
- 2013-11-26 ES ES13824177.3T patent/ES2643902T3/es active Active
-
2017
- 2017-10-17 HR HRP20171573TT patent/HRP20171573T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201591023A1 (ru) | 2015-09-30 |
| LT2928896T (lt) | 2017-09-25 |
| EA028031B1 (ru) | 2017-09-29 |
| MA38100A1 (fr) | 2017-12-29 |
| JP2016502531A (ja) | 2016-01-28 |
| SI2928896T1 (sl) | 2017-10-30 |
| JP6310474B2 (ja) | 2018-04-11 |
| ES2643902T3 (es) | 2017-11-27 |
| HUE036665T2 (hu) | 2018-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015021888A8 (pt) | inibidores de dna-pk, seus usos e composição farmacêutica | |
| BR112015015468B8 (pt) | Composto, e, composição farmacêutica | |
| WO2013184876A8 (en) | Benzo [c] isoxazoloazepine bromodomain inhibitors and uses thereof | |
| IN2012DN06720A (es) | ||
| BR112013013167A8 (pt) | inibidores de bromodomínio e usos dos mesmos | |
| BR112016011484A2 (pt) | Derivados de imidazopirimidina como moduladores de atividade de tnf | |
| CL2014001664A1 (es) | Compuestos derivados de 2-([1,4]dioxan-2-ilmetoxi)-6,7-dihidropirimido[6,1-a]isoquinolin-4-ona, antagonistas del receptor gpr84; composicion farmaceutica; metodo de tratamiento o profilaxis; y uso en el tratamiento o profilaxis de afecciones inflamatorias tales como artritis reumatoide, vasculitis, asma y psoriasis, entre otras. | |
| CR20130339A (es) | Nuevos derivados heterocíclicos y su uso en el tratamiento de desordenes neurológicos | |
| CL2007002708A1 (es) | Compuestos derivados de pirrolo[2,3-b]piridina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, caquexia, trastornos inflamatorios, entre otros. | |
| IN2014DN09352A (es) | ||
| WO2014106238A8 (en) | Heterocyclic compounds and methods of use thereof | |
| IN2014DN09348A (es) | ||
| PE20121617A1 (es) | Derivados de oxazina como inhibidores de bace | |
| BRPI0916286B8 (pt) | amidofenóxi-indazóis úteis como inibidores de c-met, seus usos, e composição farmacêutica | |
| CL2014002386A1 (es) | Compuesto inhibidor de cinasa de fosfoinositida 3 en forma anhidra cristalina solida; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento o prevencion de enfermedades tales como epoc, asma, entre otras. | |
| CL2014001838A1 (es) | Compuestos derivados de fluormetil-5,6-dihidro-4h-[1,3]oxazin-2-ilamina, como inhibidores de la bace1; su proceso de obtencion; composicion farmaceutica que los contiene; y su uso para el tratamiento terapeutico y/o profilactico de la enfermedad de alzheimer, esclerosis lateral amiotrofica, cancer, enfermedades cardiovasculares y enfermedades gastrointestinales, entre otras. | |
| CO6852073A2 (es) | Antagonistas trpm8 y su uso en tratamientos | |
| NI201600047A (es) | Tienouracilcarboxamidas cíclicas y usos de las mismas | |
| MX2013002118A (es) | 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. | |
| WO2014014794A3 (en) | Mineralocorticoid receptor antagonists | |
| TR201005325A2 (tr) | Atorvastatin ve aspirin içeren farmasötik formülasyonlar | |
| MX2015001657A (es) | Compuestos de cianopirazol substituidos con receptores de acido lisofosfatidico (lpar). | |
| CL2013001445A1 (es) | Compuestos derivados de difenilamina; composicion farmaceutica y uso en el tratamiento de enfermedades inflamatorias, tales como cancer. | |
| HRP20171573T1 (hr) | Čvrsti oblik derivata dihidro-pirido-oksazina | |
| CL2013002832A1 (es) | Compuestos derivados del acido 7-(heteroaril-amino)-6,7,8,9-tetrahidropirido[1,2-a]indol acetico, moduladores del receptor de prostaglandina d2; composicion farmaceutica; y uso en la prevencion y el tratamiento de enfermedades alergicas e inmunes tales como asma. |